OLAPARIB

OLAPARIB was reported 21443 times

OLAPARIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HIGH GRADE B-CELL LYMPHOMA BURKITT-LIKE LYMPHOMA RECURRENT 11 0.6471
1 BRCA2 GENE MUTATION 23 0.2421
2 ACUTE ERYTHROID LEUKAEMIA 14 0.2222
3 OVARIAN CANCER RECURRENT 356 0.2214
4 BRCA1 GENE MUTATION 16 0.1818
5 CARBOHYDRATE ANTIGEN 125 5 0.1667
6 ACUTE MEGAKARYOCYTIC LEUKAEMIA 8 0.1455
7 MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS 12 0.0984
8 ANGIOLIPOMA 6 0.0938
9 TP53 GENE MUTATION 9 0.0928
10 CARBOHYDRATE ANTIGEN 125 INCREASED 300 0.0879
11 MUSCULOSKELETAL TOXICITY 11 0.0591
12 OLIGODENDROGLIOMA 7 0.0583
13 FALLOPIAN TUBE CANCER 8 0.0556
14 TUMOUR MARKER ABNORMAL 17 0.0514
15 METASTASES TO RETROPERITONEUM 8 0.0471
16 ENDOMETRIAL CANCER RECURRENT 6 0.0458
17 OVARIAN CANCER METASTATIC 37 0.0435
18 MALIGNANT PERITONEAL NEOPLASM 23 0.0389
19 TUMOUR MARKER INCREASED 185 0.0385
20 MALIGNANT NEOPLASM OLIGOPROGRESSION 7 0.0352
21 MYELODYSPLASTIC SYNDROME 493 0.0341
22 PANCREATIC CARCINOMA RECURRENT 8 0.0332
23 ACUTE MONOCYTIC LEUKAEMIA 6 0.0330
24 POROKERATOSIS 6 0.0326
25 METASTASES TO PERITONEUM 82 0.0324
26 CYSTITIS RADIATION 6 0.0311
27 ACQUIRED GENE MUTATION 40 0.0305
28 METASTASES TO PLEURA 32 0.0305
29 METASTASES TO ABDOMINAL CAVITY 15 0.0305
30 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 9 0.0288
31 ASTROCYTOMA 11 0.0278
32 HORMONE-REFRACTORY PROSTATE CANCER 29 0.0244
33 MYELOID LEUKAEMIA 12 0.0240
34 OVARIAN CANCER STAGE IV 10 0.0239
35 METASTASES TO SOFT TISSUE 6 0.0232
36 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 15 0.0229
37 ACUTE MYELOID LEUKAEMIA 355 0.0228
38 METASTASES TO PELVIS 14 0.0222
39 RECURRENT CANCER 88 0.0216
40 METASTASES TO NECK 6 0.0215
41 METASTASES TO BREAST 7 0.0211
42 MALIGNANT NEOPLASM PROGRESSION 2129 0.0208
43 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 21 0.0202
44 OVARIAN CANCER STAGE III 7 0.0202
45 TRIPLE NEGATIVE BREAST CANCER 13 0.0193
46 INTESTINAL METASTASIS 7 0.0193
47 HAEMATOTOXICITY 181 0.0190
48 MALIGNANT ASCITES 14 0.0183
49 DUCTAL ADENOCARCINOMA OF PANCREAS 5 0.0181
50 METASTASES TO LYMPH NODES 117 0.0173
51 CARBOHYDRATE ANTIGEN 19-9 INCREASED 9 0.0170
52 SARS-COV-2 TEST NEGATIVE 11 0.0163
53 PELVIC MASS 13 0.0161
54 ACUTE LEUKAEMIA 26 0.0161
55 PROSTATIC SPECIFIC ANTIGEN DECREASED 6 0.0159
56 HAEMATOLOGY TEST ABNORMAL 5 0.0156
57 MYELODYSPLASTIC SYNDROME TRANSFORMATION 8 0.0154
58 METASTASES TO STOMACH 6 0.0153
59 PROSTATIC SPECIFIC ANTIGEN INCREASED 211 0.0153
60 BLAST CELLS PRESENT 7 0.0146
61 METASTASES TO CHEST WALL 5 0.0144
62 MECHANICAL ILEUS 8 0.0140
63 RED BLOOD CELL COUNT ABNORMAL 20 0.0136
64 IMPLANT SITE REACTION 6 0.0132
65 METASTASES TO MENINGES 30 0.0132
66 CARBOHYDRATE ANTIGEN 15-3 INCREASED 10 0.0131
67 METASTASIS 92 0.0129
68 MYELOSUPPRESSION 455 0.0126
69 BLOOD CREATINE ABNORMAL 6 0.0124
70 METASTASES TO LIVER 219 0.0124
71 METASTASES TO THE MEDIASTINUM 5 0.0121
72 METASTASES TO BONE MARROW 6 0.0120
73 HYPERCREATININAEMIA 6 0.0119
74 APLASIA PURE RED CELL 41 0.0119
75 METASTASES TO BONE 193 0.0117
76 RED BLOOD CELL ABNORMALITY 11 0.0114
77 OVARIAN CANCER 101 0.0109
78 METASTASES TO CENTRAL NERVOUS SYSTEM 141 0.0109
79 FULL BLOOD COUNT ABNORMAL 115 0.0109
80 PRODUCT DIFFICULT TO SWALLOW 11 0.0108
81 CREATININE RENAL CLEARANCE ABNORMAL 5 0.0108
82 INTRA-ABDOMINAL FLUID COLLECTION 19 0.0106
83 MEAN CELL VOLUME ABNORMAL 5 0.0106
84 LYMPHANGIOSIS CARCINOMATOSA 11 0.0106
85 IMMUNE-MEDIATED THYROIDITIS 5 0.0101
86 PROSTATE CANCER RECURRENT 6 0.0097
87 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 12 0.0096
88 HEART FAILURE WITH REDUCED EJECTION FRACTION 5 0.0093
89 HAEMOGLOBIN ABNORMAL 60 0.0093
90 PERITONEAL DISORDER 6 0.0093
91 LEUKAEMIA 85 0.0090
92 HAEMATOCRIT ABNORMAL 11 0.0089
93 BREAST CANCER RECURRENT 28 0.0089
94 ACUTE PROMYELOCYTIC LEUKAEMIA 9 0.0088
95 ANAEMIA 1670 0.0087
96 METASTASES TO SKIN 9 0.0087
97 PROSTATE CANCER METASTATIC 29 0.0087
98 METASTASES TO LUNG 98 0.0085
99 FULL BLOOD COUNT DECREASED 170 0.0084
100 MALIGNANT PLEURAL EFFUSION 14 0.0083
101 BLOOD FOLATE DECREASED 6 0.0083
102 CROSS SENSITIVITY REACTION 8 0.0082
103 METASTASES TO SPINE 27 0.0080
104 INTERSTITIAL LUNG DISEASE 389 0.0080
105 NEOPLASM RECURRENCE 27 0.0080
106 HYPERSENSITIVITY PNEUMONITIS 9 0.0079
107 BONE MARROW DISORDER 23 0.0076
108 BONE MARROW TOXICITY 9 0.0076
109 GENE MUTATION 15 0.0076
110 NEUROPATHY PERIPHERAL 709 0.0074
111 SECOND PRIMARY MALIGNANCY 58 0.0070
112 FOLATE DEFICIENCY 8 0.0069
113 MACROCYTOSIS 8 0.0069
114 RED BLOOD CELL COUNT DECREASED 195 0.0068
115 CORNEAL DEPOSITS 5 0.0067
116 BLAST CELL COUNT INCREASED 7 0.0067
117 ILEUS 83 0.0067
118 ANAEMIA MACROCYTIC 14 0.0066
119 PELVIC DISCOMFORT 6 0.0063
120 TASTE DISORDER 127 0.0063
121 ONCOLOGIC COMPLICATION 6 0.0062
122 VOCAL CORD PARALYSIS 11 0.0061
123 PLEURAL FIBROSIS 6 0.0059
124 INTESTINAL MASS 8 0.0058
125 MEAN CELL VOLUME INCREASED 15 0.0058
126 SUBILEUS 12 0.0058
127 CREATININE RENAL CLEARANCE DECREASED 23 0.0057
128 PANCYTOPENIA 321 0.0057
129 NEUTROPHIL COUNT DECREASED 231 0.0057
130 BLOOD SODIUM ABNORMAL 6 0.0056
131 DEATH 4833 0.0056
132 METASTATIC NEOPLASM 24 0.0056
133 SHOULDER FRACTURE 9 0.0055
134 CANCER PAIN 14 0.0055
135 OCULAR TOXICITY 6 0.0054
136 IMMUNE-MEDIATED ADVERSE REACTION 8 0.0052
137 COLON NEOPLASM 5 0.0052
138 CYTOPENIA 62 0.0051
139 BREAST CANCER METASTATIC 54 0.0050
140 BLOOD MAGNESIUM DECREASED 43 0.0050
141 DEVICE RELATED SEPSIS 10 0.0050
142 HAEMATOLOGICAL INFECTION 12 0.0049
143 HEPATIC NEOPLASM 16 0.0049
144 ASCITES 143 0.0049
145 PNEUMONITIS 132 0.0048
146 NEOPLASM 55 0.0048
147 RADIOTHERAPY 9 0.0047
148 RENAL IMPAIRMENT 395 0.0047
149 GLIOBLASTOMA 8 0.0047
150 SUPERINFECTION 7 0.0047
151 PULMONARY TOXICITY 33 0.0047
152 BONE NEOPLASM 5 0.0046
153 MASTECTOMY 8 0.0046
154 LUNG OPACITY 12 0.0045
155 DISEASE PROGRESSION 537 0.0045
156 PNEUMOCYSTIS JIROVECII PNEUMONIA 45 0.0045
157 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 10 0.0045
158 HAEMOGLOBIN DECREASED 456 0.0044
159 BONE LESION 16 0.0044
160 BONE MARROW FAILURE 90 0.0044
161 B-CELL LYMPHOMA 15 0.0044
162 GASTROINTESTINAL TOXICITY 21 0.0044
163 BONE CANCER 19 0.0044
164 OTOTOXICITY 8 0.0043
165 BLOOD CREATINE INCREASED 19 0.0043
166 ERYTHEMA NODOSUM 15 0.0043
167 WHITE BLOOD CELL COUNT ABNORMAL 27 0.0042
168 CARCINOEMBRYONIC ANTIGEN INCREASED 8 0.0041
169 DRUG RESISTANCE 106 0.0041
170 RENAL FUNCTION TEST ABNORMAL 19 0.0041
171 RED CELL DISTRIBUTION WIDTH INCREASED 17 0.0041
172 NORMOCYTIC ANAEMIA 6 0.0041
173 PULMONARY THROMBOSIS 44 0.0040
174 CHOLANGIOCARCINOMA 6 0.0040
175 LARGE INTESTINAL OBSTRUCTION 9 0.0040
176 BLOOD DISORDER 32 0.0040
177 PLATELET COUNT ABNORMAL 24 0.0040
178 INTESTINAL OBSTRUCTION 149 0.0039
179 DERMATOMYOSITIS 10 0.0039
180 HEPATIC LESION 17 0.0039
181 DYSCHEZIA 12 0.0039
182 NEUTROPHIL COUNT ABNORMAL 11 0.0039
183 IMMUNE-MEDIATED LUNG DISEASE 7 0.0038
184 PLATELET COUNT DECREASED 408 0.0038
185 GLOMERULAR FILTRATION RATE DECREASED 47 0.0038
186 RENAL NEOPLASM 8 0.0038
187 BLOOD CREATININE ABNORMAL 13 0.0038
188 ABDOMINAL MASS 10 0.0037
189 MEAN CELL HAEMOGLOBIN INCREASED 6 0.0036
190 HERNIA 69 0.0036
191 SMALL INTESTINAL OBSTRUCTION 43 0.0035
192 LYMPHOEDEMA 24 0.0035
193 IMMUNE-MEDIATED HEPATITIS 7 0.0034
194 PERIPHERAL SENSORY NEUROPATHY 20 0.0034
195 THROMBOCYTOPENIA 381 0.0034
196 LYMPHOPENIA 48 0.0034
197 WHITE BLOOD CELL DISORDER 9 0.0034
198 DECREASED ACTIVITY 36 0.0033
199 WEIGHT ABNORMAL 8 0.0033
200 CUTANEOUS VASCULITIS 12 0.0033
201 PLASMACYTOMA 6 0.0032
202 ENDOMETRIAL CANCER 7 0.0032
203 PLATELET DISORDER 8 0.0032
204 LIP DISORDER 6 0.0032
205 HYPOPROTEINAEMIA 6 0.0032
206 VITAMIN B12 DECREASED 9 0.0031
207 AORTIC ARTERIOSCLEROSIS 8 0.0031
208 NAIL DISCOLOURATION 12 0.0030
209 BLOOD CALCIUM ABNORMAL 5 0.0030
210 HEPATIC CYST 10 0.0029
211 OSTEOLYSIS 6 0.0029
212 AUTOIMMUNE HAEMOLYTIC ANAEMIA 10 0.0029
213 RENAL MASS 6 0.0029
214 CHEMOTHERAPY 11 0.0029
215 RED BLOOD CELL COUNT INCREASED 8 0.0029
216 WHITE BLOOD CELL COUNT DECREASED 312 0.0029
217 ABDOMINAL HERNIA 13 0.0028
218 IMMUNE THROMBOCYTOPENIA 13 0.0028
219 JUGULAR VEIN THROMBOSIS 5 0.0028
220 BLOOD IRON DECREASED 33 0.0028
221 BLOOD TEST ABNORMAL 39 0.0028
222 BLOOD CREATININE INCREASED 179 0.0027
223 NEGATIVE THOUGHTS 8 0.0027
224 BRAIN NEOPLASM 25 0.0027
225 GRANULOCYTE COUNT DECREASED 5 0.0027
226 COMPUTERISED TOMOGRAM ABNORMAL 6 0.0026
227 SUDDEN CARDIAC DEATH 9 0.0026
228 PERIARTHRITIS 6 0.0026
229 BILE DUCT OBSTRUCTION 5 0.0026
230 THERAPY PARTIAL RESPONDER 41 0.0026
231 HAEMATOCRIT DECREASED 52 0.0026
232 BRAIN FOG 41 0.0026
233 HEPATIC MASS 5 0.0026
234 INVASIVE DUCTAL BREAST CARCINOMA 7 0.0026
235 BLOOD COUNT ABNORMAL 39 0.0026
236 PERFORMANCE STATUS DECREASED 12 0.0026
237 HAEMOLYTIC ANAEMIA 23 0.0026
238 TYPE IV HYPERSENSITIVITY REACTION 7 0.0026
239 THERAPY CHANGE 25 0.0025
240 HYDRONEPHROSIS 19 0.0025
241 LYMPHADENOPATHY 89 0.0025
242 OBSTRUCTION 10 0.0025
243 BRAIN NEOPLASM MALIGNANT 11 0.0025
244 THROMBOSIS 198 0.0025
245 NEOPLASM MALIGNANT 164 0.0025
246 DECREASED APPETITE 565 0.0024
247 PLEURAL EFFUSION 147 0.0024
248 APPETITE DISORDER 16 0.0024
249 NAUSEA 1903 0.0024
250 HYPOPHAGIA 61 0.0024
251 FATIGUE 1836 0.0024
252 ABDOMINAL INFECTION 6 0.0023
253 IMMUNODEFICIENCY 35 0.0023
254 PHYSICAL DECONDITIONING 6 0.0023
255 PULMONARY MASS 34 0.0023
256 ADENOCARCINOMA 5 0.0022
257 BOWEL MOVEMENT IRREGULARITY 17 0.0022
258 POLYNEUROPATHY 26 0.0022
259 EMBOLISM 18 0.0022
260 NEOPLASM PROGRESSION 75 0.0022
261 DISCOURAGEMENT 5 0.0021
262 LABORATORY TEST ABNORMAL 63 0.0021
263 FEEDING DISORDER 43 0.0021
264 BONE PAIN 124 0.0021
265 CARDIAC FAILURE CHRONIC 9 0.0021
266 TUMOUR HAEMORRHAGE 6 0.0021
267 NEPHRITIS 7 0.0021
268 CONSTIPATION 450 0.0021
269 ONYCHOCLASIS 14 0.0020
270 INFREQUENT BOWEL MOVEMENTS 5 0.0020
271 NODULE 26 0.0020
272 PAROSMIA 15 0.0020
273 DEPRESSIVE SYMPTOM 7 0.0020
274 VITAMIN B12 DEFICIENCY 8 0.0020
275 PROTEINURIA 37 0.0019
276 CACHEXIA 10 0.0019
277 APLASTIC ANAEMIA 10 0.0019
278 ENTEROCOLITIS 11 0.0019
279 IRIDOCYCLITIS 6 0.0019
280 HUMERUS FRACTURE 9 0.0019
281 HEPATIC FUNCTION ABNORMAL 69 0.0018
282 NEUTROPENIA 249 0.0018
283 TONGUE DISCOLOURATION 8 0.0018
284 UNDERDOSE 133 0.0018
285 LISTLESS 6 0.0018
286 NEAR DEATH EXPERIENCE 6 0.0018
287 BLOOD SODIUM DECREASED 34 0.0018
288 LEUKOPENIA 90 0.0018
289 FAECES HARD 7 0.0018
290 MASS 25 0.0018
291 POTENTIATING DRUG INTERACTION 6 0.0018
292 GASTRITIS 47 0.0018
293 HYPOTHYROIDISM 57 0.0018
294 DRUG TOLERANCE DECREASED 5 0.0018
295 PNEUMONIA FUNGAL 7 0.0018
296 ORAL DISORDER 13 0.0018
297 ACUTE LYMPHOCYTIC LEUKAEMIA 5 0.0018
298 CEREBRAL DISORDER 13 0.0018
299 HAEMATOLOGICAL MALIGNANCY 5 0.0018
300 REGURGITATION 6 0.0017
301 BENIGN PROSTATIC HYPERPLASIA 9 0.0017
302 HAIR GROWTH ABNORMAL 12 0.0017
303 LOCALISED OEDEMA 8 0.0017
304 ASTHENIA 650 0.0017
305 HISTIOCYTOSIS HAEMATOPHAGIC 5 0.0017
306 GASTROINTESTINAL PERFORATION 7 0.0017
307 PRODUCT USE ISSUE 314 0.0017
308 NON-SMALL CELL LUNG CANCER 8 0.0017
309 DYSPHAGIA 158 0.0017
310 TERMINAL STATE 11 0.0016
311 DYSPEPSIA 161 0.0016
312 INCORRECT DOSAGE ADMINISTERED 8 0.0016
313 PULMONARY OEDEMA 73 0.0016
314 PANCREATIC DISORDER 8 0.0016
315 MYOPATHY 14 0.0016
316 HYPERVOLAEMIA 8 0.0016
317 VOMITING 761 0.0016
318 RENAL DISORDER 75 0.0016
319 ORAL PAIN 36 0.0016
320 SKIN TOXICITY 9 0.0016
321 PARANASAL SINUS DISCOMFORT 6 0.0016
322 ABDOMINAL ABSCESS 7 0.0016
323 ABDOMINAL ADHESIONS 5 0.0016
324 STOMATITIS 96 0.0016
325 HYPERTRANSAMINASAEMIA 11 0.0016
326 DYSGEUSIA 117 0.0016
327 ENTERITIS 10 0.0016
328 OESOPHAGEAL ULCER 6 0.0016
329 LYMPHOCYTE COUNT INCREASED 5 0.0015
330 HEPATOTOXICITY 34 0.0015
331 PNEUMONIA BACTERIAL 14 0.0015
332 PRODUCT USE COMPLAINT 24 0.0015
333 DRUG INTOLERANCE 147 0.0015
334 PRODUCT DOSE OMISSION IN ERROR 43 0.0015
335 INTESTINAL PERFORATION 17 0.0015
336 RHINITIS 12 0.0015
337 LOWER GASTROINTESTINAL HAEMORRHAGE 11 0.0015
338 DRUG ERUPTION 26 0.0015
339 VASCULITIS 17 0.0015
340 ILLNESS 150 0.0015
341 EATING DISORDER 31 0.0015
342 PRODUCT DOSE OMISSION ISSUE 427 0.0015
343 MUCOSAL INFLAMMATION 38 0.0014
344 DEPRESSION SUICIDAL 5 0.0014
345 AGEUSIA 36 0.0014
346 PETECHIAE 15 0.0014
347 TONGUE DISCOMFORT 6 0.0014
348 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
349 BLOOD PRESSURE ABNORMAL 28 0.0014
350 PERONEAL NERVE PALSY 8 0.0014
351 FEBRILE NEUTROPENIA 93 0.0014
352 PRODUCT DISTRIBUTION ISSUE 13 0.0014
353 FLUID INTAKE REDUCED 7 0.0014
354 GINGIVAL BLEEDING 19 0.0014
355 RENAL CYST 11 0.0014
356 MONOPLEGIA 6 0.0014
357 DYSLIPIDAEMIA 7 0.0014
358 INSURANCE ISSUE 21 0.0014
359 INTENTIONAL UNDERDOSE 10 0.0014
360 IMMUNE-MEDIATED ENTEROCOLITIS 5 0.0014
361 RENAL FAILURE 179 0.0013
362 BRAIN OEDEMA 17 0.0013
363 TOXICITY TO VARIOUS AGENTS 223 0.0013
364 URINE ABNORMALITY 6 0.0013
365 HOSPICE CARE 13 0.0013
366 INTERNAL HAEMORRHAGE 15 0.0013
367 NEUROTOXICITY 23 0.0013
368 GASTROINTESTINAL MOTILITY DISORDER 7 0.0013
369 GASTRIC INFECTION 5 0.0013
370 LUNG DISORDER 64 0.0013
371 LYMPHOCYTE COUNT DECREASED 23 0.0013
372 LUNG INFECTION 20 0.0013
373 GENERAL PHYSICAL HEALTH DETERIORATION 148 0.0013
374 NEUTROPENIC SEPSIS 9 0.0013
375 DEHYDRATION 168 0.0013
376 DYSPNOEA EXERTIONAL 47 0.0012
377 PANCREATIC CARCINOMA 36 0.0012
378 BLOOD CALCIUM DECREASED 14 0.0012
379 HYPERTHYROIDISM 18 0.0012
380 TRANSFUSION 13 0.0012
381 ADRENAL INSUFFICIENCY 15 0.0012
382 NOCTURIA 15 0.0012
383 LYMPHOMA 19 0.0012
384 HEPATIC FAILURE 37 0.0012
385 GASTROINTESTINAL INFECTION 11 0.0012
386 DISEASE RECURRENCE 58 0.0012
387 LIVER DISORDER 54 0.0012
388 HIP FRACTURE 39 0.0012
389 ALANINE AMINOTRANSFERASE INCREASED 74 0.0012
390 ASPARTATE AMINOTRANSFERASE INCREASED 64 0.0012
391 PROTEIN URINE PRESENT 6 0.0012
392 ABDOMINAL DISTENSION 125 0.0012
393 SPINAL PAIN 14 0.0012
394 HOT FLUSH 90 0.0012
395 ERYSIPELAS 6 0.0012
396 OESOPHAGITIS 13 0.0012
397 HYPERCHLORHYDRIA 7 0.0012
398 DEAFNESS 31 0.0012
399 ABDOMINAL DISCOMFORT 197 0.0012
400 RETCHING 25 0.0012
401 HYPOKINESIA 17 0.0012
402 HYPOKALAEMIA 54 0.0012
403 WRIST FRACTURE 14 0.0012
404 BLOOD POTASSIUM DECREASED 35 0.0012
405 TYPE 1 DIABETES MELLITUS 7 0.0012
406 APHTHOUS ULCER 9 0.0012
407 PULMONARY EMBOLISM 110 0.0012
408 HYPERSOMNIA 33 0.0011
409 GASTROINTESTINAL DISORDER 103 0.0011
410 HYPOMAGNESAEMIA 16 0.0011
411 DRUG-INDUCED LIVER INJURY 36 0.0011
412 DIVERTICULUM INTESTINAL 5 0.0011
413 NAIL DISORDER 10 0.0011
414 COLON CANCER 17 0.0011
415 BLOOD LACTIC ACID INCREASED 6 0.0011
416 IMMUNE SYSTEM DISORDER 15 0.0011
417 PULMONARY CONGESTION 15 0.0011
418 PIGMENTATION DISORDER 7 0.0011
419 GINGIVAL PAIN 9 0.0011
420 CHOLANGITIS 7 0.0011
421 BLOOD ALKALINE PHOSPHATASE INCREASED 28 0.0011
422 PERICARDIAL EFFUSION 26 0.0011
423 PRODUCT USE IN UNAPPROVED INDICATION 278 0.0011
424 UTERINE CANCER 9 0.0011
425 COMPRESSION FRACTURE 6 0.0011
426 IRON DEFICIENCY 5 0.0011
427 FRACTURE 21 0.0011
428 OFF LABEL USE 971 0.0011
429 PRODUCT PRESCRIBING ISSUE 24 0.0011
430 RESTLESS LEGS SYNDROME 20 0.0011
431 LIMB DISCOMFORT 34 0.0011
432 PERIPHERAL SWELLING 169 0.0011
433 PULMONARY FIBROSIS 21 0.0011
434 HEPATITIS 28 0.0011
435 UROSEPSIS 10 0.0011
436 CARDIAC FLUTTER 7 0.0011
437 DRUG EFFECT LESS THAN EXPECTED 16 0.0011
438 HAEMORRHAGE INTRACRANIAL 16 0.0011
439 NEPHROPATHY TOXIC 12 0.0011
440 FLANK PAIN 10 0.0011
441 PERITONITIS 22 0.0011
442 LIVER INJURY 26 0.0011
443 FLATULENCE 60 0.0011
444 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
445 MYALGIA 179 0.0011
446 MENINGITIS 7 0.0010
447 BLOOD POTASSIUM INCREASED 17 0.0010
448 EPILEPSY 32 0.0010
449 EXERCISE TOLERANCE DECREASED 6 0.0010
450 PYELONEPHRITIS 9 0.0010
451 THYROID DISORDER 16 0.0010
452 HAEMOLYSIS 8 0.0010
453 MUSCULOSKELETAL CHEST PAIN 16 0.0010
454 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 24 0.0010
455 PHARYNGEAL SWELLING 10 0.0010
456 ABDOMINAL PAIN UPPER 210 0.0010
457 KIDNEY INFECTION 20 0.0010
458 ABDOMINAL PAIN 237 0.0010
459 COVID-19 PNEUMONIA 12 0.0010
460 ENCEPHALITIS 7 0.0010
461 BLOOD LACTATE DEHYDROGENASE INCREASED 16 0.0010
462 ABDOMINAL TENDERNESS 5 0.0010
463 INTENTIONAL PRODUCT MISUSE 88 0.0010
464 HEPATIC ENZYME ABNORMAL 5 0.0010
465 OROPHARYNGEAL DISCOMFORT 9 0.0010
466 OEDEMA 54 0.0010
467 GASTROOESOPHAGEAL REFLUX DISEASE 80 0.0010
468 HAEMATURIA 34 0.0010
469 TRANSAMINASES INCREASED 22 0.0010
470 RASH MACULO-PAPULAR 22 0.0010
471 MULTIPLE ORGAN DYSFUNCTION SYNDROME 28 0.0010
472 DIARRHOEA 638 0.0010
473 INTENTIONAL DOSE OMISSION 28 0.0010
474 ERUCTATION 19 0.0010
475 HAEMATOCHEZIA 54 0.0010
476 ABNORMAL FAECES 8 0.0010
477 UPPER-AIRWAY COUGH SYNDROME 8 0.0010
478 SPINAL COMPRESSION FRACTURE 8 0.0010
479 FAILURE TO THRIVE 5 0.0010
480 DIPLOPIA 25 0.0010
481 FAECES SOFT 7 0.0010
482 MYOCARDITIS 11 0.0010
483 GAIT INABILITY 32 0.0010
484 BLOOD UREA INCREASED 16 0.0010
485 FOOD CRAVING 5 0.0009
486 MUSCLE ATROPHY 12 0.0009
487 HAEMATEMESIS 24 0.0009
488 CARDIAC FAILURE 76 0.0009
489 CYSTITIS 30 0.0009
490 BODY HEIGHT DECREASED 10 0.0009
491 THERAPY CESSATION 48 0.0009
492 FOOD POISONING 5 0.0009
493 ARTHRALGIA 388 0.0009
494 APHONIA 13 0.0009
495 DISSEMINATED INTRAVASCULAR COAGULATION 13 0.0009
496 HAEMORRHOIDS 18 0.0009
497 TROPONIN INCREASED 7 0.0009
498 TRANSIENT ISCHAEMIC ATTACK 31 0.0009
499 HYDROCEPHALUS 5 0.0009
500 URINE OUTPUT DECREASED 8 0.0009
501 WOUND INFECTION 10 0.0009
502 ASPIRATION 10 0.0009
503 FAECALOMA 5 0.0009
504 BLOOD CALCIUM INCREASED 8 0.0009
505 DRUG INTERACTION 144 0.0009
506 CORONAVIRUS INFECTION 6 0.0009
507 IMMUNOSUPPRESSION 8 0.0009
508 BACK PAIN 210 0.0009
509 WEIGHT DECREASED 252 0.0009
510 MOUTH ULCERATION 19 0.0009
511 HYPOALBUMINAEMIA 7 0.0009
512 PELVIC FRACTURE 7 0.0009
513 CARDIOTOXICITY 8 0.0009
514 HEART RATE ABNORMAL 5 0.0009
515 DEMENTIA 25 0.0009
516 ANGIOPATHY 5 0.0009
517 MALAISE 391 0.0009
518 BRONCHIECTASIS 6 0.0009
519 CATARACT 53 0.0009
520 BLOOD BILIRUBIN INCREASED 24 0.0009
521 LOWER LIMB FRACTURE 17 0.0009
522 GENERAL PHYSICAL CONDITION ABNORMAL 6 0.0009
523 EPISTAXIS 66 0.0009
524 HYPOAESTHESIA 132 0.0009
525 NEUTROPHIL COUNT INCREASED 9 0.0009
526 BLOOD TESTOSTERONE DECREASED 6 0.0009
527 JOINT STIFFNESS 23 0.0009
528 INCREASED TENDENCY TO BRUISE 8 0.0009
529 BLOOD THYROID STIMULATING HORMONE INCREASED 8 0.0009
530 FRUSTRATION TOLERANCE DECREASED 7 0.0009
531 HEPATIC CYTOLYSIS 11 0.0009
532 DEEP VEIN THROMBOSIS 56 0.0009
533 SEPSIS 96 0.0009
534 ELECTROLYTE IMBALANCE 10 0.0009
535 DECUBITUS ULCER 7 0.0009
536 ERYTHEMA MULTIFORME 8 0.0009
537 CELLULITIS 43 0.0009
538 SKIN REACTION 12 0.0009
539 HEPATIC ENZYME INCREASED 58 0.0008
540 ARTERIOSCLEROSIS 8 0.0008
541 PYREXIA 293 0.0008
542 PLATELET COUNT INCREASED 11 0.0008
543 EOSINOPHIL COUNT INCREASED 7 0.0008
544 LIVER FUNCTION TEST INCREASED 18 0.0008
545 RHINORRHOEA 54 0.0008
546 LETHARGY 48 0.0008
547 CANDIDA INFECTION 14 0.0008
548 NEPHROLITHIASIS 38 0.0008
549 HYPERTENSION 174 0.0008
550 VITAMIN D DECREASED 7 0.0008
551 GASTROINTESTINAL PAIN 9 0.0008
552 URINARY TRACT INFECTION 139 0.0008
553 MUSCLE STRAIN 7 0.0008
554 GENERALISED OEDEMA 10 0.0008
555 SLEEP DISORDER 57 0.0008
556 INABILITY TO AFFORD MEDICATION 8 0.0008
557 SUNBURN 6 0.0008
558 MALNUTRITION 9 0.0008
559 BACTERIAL INFECTION 15 0.0008
560 DISCOMFORT 49 0.0008
561 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 6 0.0008
562 SPINAL FRACTURE 16 0.0008
563 SPINAL OSTEOARTHRITIS 7 0.0008
564 PRODUCT DOSE OMISSION 52 0.0008
565 HYPOAESTHESIA ORAL 12 0.0008
566 LUNG INFILTRATION 7 0.0008
567 BLOOD PRESSURE FLUCTUATION 19 0.0008
568 DYSPHONIA 46 0.0008
569 CYTOMEGALOVIRUS INFECTION 13 0.0008
570 GASTRIC HAEMORRHAGE 9 0.0008
571 LEUKOCYTOSIS 14 0.0008
572 OSTEOMYELITIS 14 0.0008
573 PROSTATE CANCER 62 0.0008
574 HEPATITIS ACUTE 5 0.0008
575 HYPERGLYCAEMIA 28 0.0008
576 HYPONATRAEMIA 43 0.0008
577 APHASIA 23 0.0008
578 BACTERAEMIA 9 0.0008
579 PNEUMOTHORAX 12 0.0008
580 BLOOD ALBUMIN DECREASED 6 0.0008
581 CHOLECYSTITIS 9 0.0008
582 RENAL PAIN 8 0.0008
583 ULCER 12 0.0008
584 HYPERLIPIDAEMIA 9 0.0008
585 INFECTION 109 0.0008
586 APPENDICITIS 7 0.0007
587 THYROID CANCER 9 0.0007
588 FLUID RETENTION 38 0.0007
589 QUALITY OF LIFE DECREASED 10 0.0007
590 BREAST MASS 5 0.0007
591 DIZZINESS 371 0.0007
592 FAECES DISCOLOURED 16 0.0007
593 BLOOD URINE PRESENT 14 0.0007
594 NERVOUS SYSTEM DISORDER 23 0.0007
595 DYSURIA 27 0.0007
596 DYSPNOEA 414 0.0007
597 HERPES ZOSTER 42 0.0007
598 ATRIAL FIBRILLATION 71 0.0007
599 PERIPHERAL COLDNESS 10 0.0007
600 OSTEONECROSIS OF JAW 18 0.0007
601 HEAD INJURY 23 0.0007
602 PHOTOSENSITIVITY REACTION 12 0.0007
603 HYPERCHOLESTEROLAEMIA 7 0.0007
604 ATELECTASIS 7 0.0007
605 NIGHT SWEATS 23 0.0007
606 COLITIS 27 0.0007
607 BLINDNESS 29 0.0007
608 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 34 0.0007
609 COVID-19 124 0.0007
610 COUGH 198 0.0007
611 HAND FRACTURE 5 0.0007
612 BLADDER DISORDER 7 0.0007
613 FACIAL PARALYSIS 6 0.0007
614 UPPER LIMB FRACTURE 14 0.0007
615 DRY MOUTH 57 0.0007
616 AGRANULOCYTOSIS 13 0.0007
617 NEURALGIA 17 0.0007
618 CEREBRAL HAEMORRHAGE 25 0.0007
619 HEPATIC STEATOSIS 13 0.0007
620 IMPAIRED QUALITY OF LIFE 10 0.0007
621 DIABETES MELLITUS 53 0.0007
622 CEREBROVASCULAR ACCIDENT 117 0.0007
623 ADVERSE DRUG REACTION 62 0.0007
624 SKIN DISORDER 23 0.0007
625 BLOOD PRESSURE INCREASED 105 0.0007
626 SLUGGISHNESS 7 0.0007
627 GROIN PAIN 6 0.0007
628 BALANCE DISORDER 59 0.0007
629 FALL 227 0.0007
630 OSTEOPOROSIS 28 0.0007
631 PARAESTHESIA 107 0.0007
632 WHITE BLOOD CELL COUNT INCREASED 26 0.0007
633 PAIN 416 0.0007
634 CARDIOMYOPATHY 10 0.0007
635 OEDEMA PERIPHERAL 82 0.0007
636 ABDOMINAL PAIN LOWER 17 0.0007
637 MUSCULAR WEAKNESS 76 0.0007
638 MYOSITIS 6 0.0007
639 HEADACHE 416 0.0007
640 SUDDEN DEATH 7 0.0007
641 VIRAL INFECTION 22 0.0007
642 OSTEOARTHRITIS 28 0.0007
643 BURSITIS 8 0.0007
644 OXYGEN SATURATION DECREASED 37 0.0007
645 GAIT DISTURBANCE 126 0.0007
646 PNEUMONIA 213 0.0007
647 BREAST PAIN 7 0.0007
648 PAIN IN EXTREMITY 193 0.0007
649 HYPERTHERMIA 5 0.0007
650 LIPASE INCREASED 5 0.0007
651 BLOOD GLUCOSE ABNORMAL 12 0.0006
652 DIVERTICULITIS 18 0.0006
653 DIFFUSE LARGE B-CELL LYMPHOMA 5 0.0006
654 MUSCLE SPASMS 119 0.0006
655 HUNGER 9 0.0006
656 CONTUSION 62 0.0006
657 BREAST CANCER 60 0.0006
658 INSOMNIA 171 0.0006
659 GASTROINTESTINAL INFLAMMATION 5 0.0006
660 SPINAL DISORDER 6 0.0006
661 FOOT FRACTURE 12 0.0006
662 POISONING DELIBERATE 6 0.0006
663 DENTAL CARIES 7 0.0006
664 C-REACTIVE PROTEIN INCREASED 23 0.0006
665 RIB FRACTURE 13 0.0006
666 FEELING ABNORMAL 151 0.0006
667 SWELLING FACE 41 0.0006
668 NERVE INJURY 7 0.0006
669 ADVERSE EVENT 58 0.0006
670 HYPERTENSIVE CRISIS 7 0.0006
671 RECTAL HAEMORRHAGE 27 0.0006
672 ALOPECIA 123 0.0006
673 HEART RATE INCREASED 62 0.0006
674 SNEEZING 14 0.0006
675 GLAUCOMA 12 0.0006
676 LIVER FUNCTION TEST ABNORMAL 18 0.0006
677 DIZZINESS POSTURAL 6 0.0006
678 HIATUS HERNIA 8 0.0006
679 RESPIRATORY FAILURE 45 0.0006
680 ISCHAEMIC STROKE 11 0.0006
681 GALLBLADDER DISORDER 11 0.0006
682 DERMATITIS CONTACT 7 0.0006
683 MEMORY IMPAIRMENT 84 0.0006
684 HEPATOMEGALY 6 0.0006
685 SYNCOPE 61 0.0006
686 ILL-DEFINED DISORDER 37 0.0006
687 ESCHERICHIA INFECTION 5 0.0006
688 POOR QUALITY SLEEP 13 0.0006
689 RASH MACULAR 21 0.0006
690 COGNITIVE DISORDER 28 0.0006
691 AMNESIA 39 0.0006
692 BRAIN INJURY 6 0.0006
693 FREQUENT BOWEL MOVEMENTS 16 0.0006
694 DRY THROAT 6 0.0006
695 HYPOTENSION 118 0.0006
696 PALLOR 16 0.0006
697 IMPAIRED GASTRIC EMPTYING 8 0.0006
698 LOSS OF CONSCIOUSNESS 75 0.0006
699 GASTRIC DISORDER 20 0.0006
700 CENTRAL NERVOUS SYSTEM LESION 8 0.0006
701 MUSCULOSKELETAL DISCOMFORT 10 0.0006
702 CHOLELITHIASIS 19 0.0006
703 GASTRIC ULCER 11 0.0006
704 THERAPY NON-RESPONDER 26 0.0006
705 MUSCULOSKELETAL DISORDER 11 0.0006
706 INCREASED APPETITE 11 0.0006
707 POLLAKIURIA 24 0.0006
708 FEELING COLD 16 0.0006
709 HAEMORRHAGE 60 0.0006
710 RASH 250 0.0006
711 WEIGHT FLUCTUATION 6 0.0006
712 SPEECH DISORDER 30 0.0006
713 BLOOD PRESSURE DECREASED 38 0.0006
714 CHILLS 67 0.0006
715 CARDIOMEGALY 7 0.0006
716 BLINDNESS UNILATERAL 8 0.0006
717 TREATMENT NONCOMPLIANCE 31 0.0006
718 SEASONAL ALLERGY 8 0.0006
719 HEAD DISCOMFORT 10 0.0006
720 ABSCESS 9 0.0006
721 SECRETION DISCHARGE 7 0.0006
722 JAUNDICE 15 0.0006
723 SOMNOLENCE 112 0.0006
724 MUSCLE TIGHTNESS 9 0.0006
725 SINUS DISORDER 11 0.0006
726 TOOTHACHE 10 0.0006
727 APATHY 8 0.0005
728 GASTROENTERITIS 8 0.0005
729 DYSSTASIA 16 0.0005
730 SWELLING 51 0.0005
731 DRUG LEVEL INCREASED 9 0.0005
732 ANGIOEDEMA 24 0.0005
733 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
734 HEPATIC CANCER 13 0.0005
735 URINARY RETENTION 18 0.0005
736 THINKING ABNORMAL 10 0.0005
737 WOUND 15 0.0005
738 MENTAL IMPAIRMENT 13 0.0005
739 MIDDLE INSOMNIA 10 0.0005
740 SKIN INFECTION 6 0.0005
741 RESPIRATORY DISORDER 16 0.0005
742 PANCREATITIS ACUTE 12 0.0005
743 FACE OEDEMA 9 0.0005
744 HEPATIC CIRRHOSIS 10 0.0005
745 PHOTOPHOBIA 10 0.0005
746 EYE INFECTION 6 0.0005
747 SARS-COV-2 TEST POSITIVE 7 0.0005
748 MOVEMENT DISORDER 17 0.0005
749 DRUG INEFFECTIVE 689 0.0005
750 MALIGNANT MELANOMA 7 0.0005
751 TINNITUS 24 0.0005
752 PALPITATIONS 61 0.0005
753 POST PROCEDURAL COMPLICATION 10 0.0005
754 IMPAIRED HEALING 17 0.0005
755 MADAROSIS 6 0.0005
756 INTENTIONAL PRODUCT USE ISSUE 45 0.0005
757 HYPERKALAEMIA 18 0.0005
758 GASTRIC CANCER 13 0.0005
759 LUNG NEOPLASM MALIGNANT 21 0.0005
760 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
761 TYPE 2 DIABETES MELLITUS 17 0.0005
762 THIRST 9 0.0005
763 RASH PRURITIC 27 0.0005
764 JOINT SWELLING 60 0.0005
765 TOOTH DISORDER 11 0.0005
766 VERTIGO 30 0.0005
767 EYELID PTOSIS 5 0.0005
768 CARDIAC DISORDER 46 0.0005
769 PARALYSIS 7 0.0005
770 EAR DISCOMFORT 5 0.0005
771 CYST 6 0.0005
772 HYPERBILIRUBINAEMIA 5 0.0005
773 EYE DISCHARGE 5 0.0005
774 DERMATITIS 10 0.0005
775 CONFUSIONAL STATE 77 0.0005
776 PERICARDITIS 8 0.0005
777 HYPOCALCAEMIA 9 0.0005
778 CHEST PAIN 88 0.0005
779 MOBILITY DECREASED 34 0.0005
780 INCONTINENCE 5 0.0005
781 DEPRESSION 107 0.0005
782 CIRCULATORY COLLAPSE 8 0.0005
783 WEIGHT INCREASED 105 0.0005
784 ROTATOR CUFF SYNDROME 6 0.0005
785 SKIN CANCER 10 0.0005
786 HYPERSENSITIVITY 86 0.0005
787 EAR PAIN 9 0.0005
788 PRODUCT DISPENSING ERROR 10 0.0005
789 TREATMENT FAILURE 38 0.0005
790 BEDRIDDEN 6 0.0005
791 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 25 0.0005
792 DEPRESSED MOOD 24 0.0005
793 CEREBRAL INFARCTION 11 0.0004
794 NECK PAIN 25 0.0004
795 INFLAMMATION 23 0.0004
796 NASOPHARYNGITIS 82 0.0004
797 SINUS CONGESTION 6 0.0004
798 HYPOACUSIS 19 0.0004
799 PELVIC PAIN 8 0.0004
800 PNEUMONIA ASPIRATION 11 0.0004
801 SCIATICA 7 0.0004
802 BONE DISORDER 8 0.0004
803 MICTURITION URGENCY 5 0.0004
804 ERYTHEMA 89 0.0004
805 DELIRIUM 15 0.0004
806 BACK DISORDER 7 0.0004
807 HAEMOPTYSIS 12 0.0004
808 TACHYCARDIA 38 0.0004
809 VISUAL IMPAIRMENT 53 0.0004
810 ANAPHYLACTIC SHOCK 11 0.0004
811 SEIZURE 49 0.0004
812 PRURITUS 163 0.0004
813 THROAT IRRITATION 19 0.0004
814 ARRHYTHMIA 20 0.0004
815 JOINT INJURY 9 0.0004
816 PRODUCT PRESCRIBING ERROR 10 0.0004
817 THERAPY INTERRUPTED 30 0.0004
818 ARTHRITIS 33 0.0004
819 ANXIETY 119 0.0004
820 PARAESTHESIA ORAL 6 0.0004
821 HEMIPARESIS 7 0.0004
822 BREAST CANCER FEMALE 11 0.0004
823 PRESYNCOPE 10 0.0004
824 BLISTER 23 0.0004
825 RHABDOMYOLYSIS 17 0.0004
826 GASTROINTESTINAL HAEMORRHAGE 34 0.0004
827 HYPERCALCAEMIA 5 0.0004
828 CHROMATURIA 9 0.0004
829 DYSARTHRIA 15 0.0004
830 HALLUCINATION 30 0.0004
831 HYPOXIA 14 0.0004
832 RASH ERYTHEMATOUS 19 0.0004
833 PRODUCT ADMINISTRATION ERROR 8 0.0004
834 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
835 OSTEOPENIA 6 0.0004
836 PRODUCT AVAILABILITY ISSUE 9 0.0004
837 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 28 0.0004
838 ACUTE KIDNEY INJURY 60 0.0004
839 SKIN DISCOLOURATION 18 0.0004
840 UPPER RESPIRATORY TRACT INFECTION 18 0.0004
841 MUSCULOSKELETAL STIFFNESS 34 0.0004
842 EJECTION FRACTION DECREASED 6 0.0004
843 INFLUENZA 43 0.0004
844 MYOCARDIAL INFARCTION 67 0.0004
845 RESPIRATORY TRACT INFECTION 10 0.0004
846 NERVOUSNESS 20 0.0004
847 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
848 CHRONIC KIDNEY DISEASE 29 0.0004
849 HYPERHIDROSIS 49 0.0004
850 PRODUCTIVE COUGH 18 0.0004
851 OBESITY 6 0.0004
852 NASAL CONGESTION 22 0.0004
853 CHEST DISCOMFORT 38 0.0004
854 FIBROMYALGIA 9 0.0004
855 SKIN LESION 10 0.0004
856 LACRIMATION INCREASED 11 0.0004
857 ACUTE RESPIRATORY FAILURE 7 0.0004
858 COAGULOPATHY 6 0.0004
859 MENTAL STATUS CHANGES 10 0.0004
860 FUNGAL INFECTION 12 0.0004
861 PANCREATITIS 19 0.0004
862 NO ADVERSE EVENT 65 0.0004
863 GLOSSODYNIA 8 0.0004
864 DISABILITY 7 0.0004
865 DISORIENTATION 14 0.0004
866 SCAR 6 0.0004
867 ANGINA PECTORIS 10 0.0003
868 CYTOKINE RELEASE SYNDROME 7 0.0003
869 SHOCK 8 0.0003
870 MIGRAINE 33 0.0003
871 VISION BLURRED 47 0.0003
872 BURNING SENSATION 24 0.0003
873 BRONCHITIS 25 0.0003
874 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0003
875 OROPHARYNGEAL PAIN 31 0.0003
876 EYE DISORDER 11 0.0003
877 STAPHYLOCOCCAL INFECTION 11 0.0003
878 EYE PRURITUS 11 0.0003
879 FEELING HOT 20 0.0003
880 ABNORMAL DREAMS 9 0.0003
881 ENCEPHALOPATHY 8 0.0003
882 DEVICE RELATED INFECTION 5 0.0003
883 PRURITUS GENERALISED 7 0.0003
884 ANKLE FRACTURE 5 0.0003
885 FEMUR FRACTURE 10 0.0003
886 EYE SWELLING 12 0.0003
887 VAGINAL HAEMORRHAGE 14 0.0003
888 DELUSION 5 0.0003
889 BASAL CELL CARCINOMA 5 0.0003
890 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
891 CARDIOVASCULAR DISORDER 8 0.0003
892 RASH PAPULAR 7 0.0003
893 HEART RATE IRREGULAR 7 0.0003
894 DRY SKIN 41 0.0003
895 SUICIDAL IDEATION 28 0.0003
896 ELECTROCARDIOGRAM QT PROLONGED 11 0.0003
897 URTICARIA 51 0.0003
898 CRYING 11 0.0003
899 BLOOD CHOLESTEROL INCREASED 14 0.0003
900 SEPTIC SHOCK 13 0.0003
901 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
902 BODY TEMPERATURE INCREASED 6 0.0003
903 EMOTIONAL DISORDER 9 0.0003
904 SWOLLEN TONGUE 9 0.0003
905 HEART RATE DECREASED 10 0.0003
906 IRRITABILITY 17 0.0003
907 PAIN IN JAW 8 0.0003
908 IMPAIRED WORK ABILITY 6 0.0003
909 IRRITABLE BOWEL SYNDROME 6 0.0003
910 CARDIAC ARREST 23 0.0003
911 TREMOR 46 0.0003
912 GASTROENTERITIS VIRAL 5 0.0003
913 MENTAL DISORDER 12 0.0003
914 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
915 COMA 13 0.0003
916 CONDITION AGGRAVATED 83 0.0003
917 SURGERY 16 0.0003
918 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 49 0.0003
919 ANAPHYLACTIC REACTION 15 0.0003
920 BLOOD GLUCOSE INCREASED 51 0.0003
921 STEVENS-JOHNSON SYNDROME 6 0.0003
922 CONJUNCTIVITIS 5 0.0003
923 LOWER RESPIRATORY TRACT INFECTION 12 0.0003
924 CHOLESTASIS 5 0.0003
925 DISTURBANCE IN ATTENTION 14 0.0003
926 LIMB INJURY 7 0.0003
927 INFUSION RELATED REACTION 17 0.0003
928 CHOKING 5 0.0003
929 INFLUENZA LIKE ILLNESS 21 0.0003
930 SINUSITIS 26 0.0003
931 RESPIRATORY DISTRESS 7 0.0003
932 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
933 PROCEDURAL PAIN 7 0.0003
934 DIABETIC KETOACIDOSIS 6 0.0002
935 HYPOGLYCAEMIA 12 0.0002
936 RESTLESSNESS 9 0.0002
937 VISUAL ACUITY REDUCED 8 0.0002
938 ROAD TRAFFIC ACCIDENT 10 0.0002
939 ACUTE MYOCARDIAL INFARCTION 7 0.0002
940 CARDIAC FAILURE CONGESTIVE 19 0.0002
941 RASH GENERALISED 6 0.0002
942 HAEMATOMA 6 0.0002
943 RHEUMATOID ARTHRITIS 26 0.0002
944 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
945 MELAENA 5 0.0002
946 DRUG DOSE OMISSION 36 0.0002
947 ARTHROPATHY 12 0.0002
948 CARDIO-RESPIRATORY ARREST 9 0.0002
949 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
950 LIP SWELLING 7 0.0002
951 EYE IRRITATION 12 0.0002
952 BLOOD GLUCOSE DECREASED 10 0.0002
953 LOCALISED INFECTION 5 0.0002
954 FLUSHING 21 0.0002
955 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
956 AGITATION 15 0.0002
957 RENAL INJURY 6 0.0002
958 SKIN EXFOLIATION 17 0.0002
959 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
960 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
961 DYSKINESIA 8 0.0002
962 MUSCULOSKELETAL PAIN 10 0.0002
963 EAR INFECTION 5 0.0002
964 FEAR 5 0.0002
965 WHEEZING 11 0.0002
966 OSTEONECROSIS 6 0.0002
967 DRY EYE 9 0.0002
968 ANGER 6 0.0002
969 INCORRECT DOSE ADMINISTERED 40 0.0002
970 UNEVALUABLE EVENT 13 0.0002
971 BRADYCARDIA 9 0.0002
972 ASTHMA 19 0.0002
973 CORONARY ARTERY DISEASE 5 0.0002
974 PANIC ATTACK 6 0.0002
975 EYE PAIN 9 0.0002
976 MOOD SWINGS 5 0.0002
977 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
978 ACNE 11 0.0001
979 HOSPITALISATION 22 0.0001
980 ACCIDENTAL OVERDOSE 5 0.0001
981 ECZEMA 7 0.0001
982 SKIN BURNING SENSATION 9 0.0001
983 EXTRA DOSE ADMINISTERED 5 0.0001
984 PRODUCT STORAGE ERROR 10 0.0001
985 INJURY 8 0.0001
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22 0.0001
987 MULTIPLE SCLEROSIS 5 0.0001
988 AGGRESSION 5 0.0001
989 EMOTIONAL DISTRESS 12 0.0001
990 EXPOSURE DURING PREGNANCY 6 0.0001
991 MEDICATION ERROR 5 0.0001
992 BLADDER CANCER 5 0.0001
993 OVERDOSE 18 0.0001
994 INJECTION SITE PAIN 5 0.0000